• Home >>
  • Pharmaceuticals and Healthcare >>
  • Healthcare CROs Market: Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Competitive Analysis 2017 - 2025

Healthcare CROs Market: Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Competitive Analysis 2017 - 2025

ID: 240301 21st May, 2018 Region : Global Pages Reports Monitor

Global healthcare contract research organization market, by type (drug discovery, pre-clinical and clinical based), services (clinical supply management, data management, regulatory, medical writing, clinical monitoring, quality management, bio-statistics, investigator payments, laboratory patient, site recruitment technology and others) forecast till 2025
Market Scenario 

Contract research organization (CRO) offers contract base outsource services to the biotechnology, pharmaceutical and medical devices companies. CRO helps other pharmaceutical or biotechnology companies to increase the productivity by focusing on their core business and results in maximising the profits. Increasing investment in R&D, patent expiration and rising competition are driving the growth of the market. Wide range of services offered by CRO such as preclinical research, biologic assay development, biopharmaceutical and pharmaceutical development, commercialization, clinical trials management, and clinical research are fuels the growth of the market. Stringent government regulations to produce safe drugs molecules are boost the pharmacovigilance activity and results in demand of the CRO market. Rising outsourcing of biopharmaceutical and pharmaceutical R&D activity, low cost of outsourcing the activities and high failure rate of drug clinical trials are favouring the growth of the contract research organization market. Increasing competition between pharmaceutical companies led to expansion of their product portfolio which raises the outsourcing business of CRO. Growing demand of new drugs in the market are supports the growth of the contract research organization. Apart from services offers by CRO today new outsoaring business can be the opportunity in the market. Stringent regulatory bodies such as FDA and lack of skilled professional workforce are hampering the growth of the contract research organization market.  


Segmentation
The global healthcare contract research organization market is segmented on the basis of type and services.
On the basis of type, the market is segmented into drug discovery, pre-clinical and clinical based.
On the basis of services, the market is segmented into clinical supply management, data management, regulatory, medical writing, clinical monitoring, quality management, bio-statistics, investigator payments, laboratory patient, site recruitment technology and others.   


Regional Analysis
Presence of major pharmaceutical companies, increasing research activity and growing number of CRO in North America is driving the growth of the market. Developing economies of Asia-Pacific region accumulate outsources business of pharmaceutical companies as rising number of companies, presence of low wage workforce and growing population are driving the growth in that region.


Key Players
Major players profiled in this market are: PAREXEL International, Charles River, Medpace and Pharmaceutical Product Development, LLC., Syneos Health, IQVIA, PRA Health Sciences, Inc., ICON PLC, Quintiles, ICON and Laboratory Corporation of America Holdings etc.  


Segmentation
By Type:
• Drug discovery 
• Pre-clinical 
• Clinical based
By Services:
• Clinical Supply Management 
• Data Management 
• Regulatory 
• Medical Writing 
• Clinical Monitoring 
• Quality Management 
• Bio-statistics 
• Investigator Payments 
• Laboratory Patient 
• Site Recruitment Technology 
• Others
By Region:
• North America
• Europe
• Asia-Pacific
• LAMEA

Research Scope
The study for Global Healthcare Contract Research Organization Market will provide market size, estimates and forecast based on the following years: 
 
Historic data: 2016  Base Year Estimate: 2017  Forecast: 2018 to 2025


The report has been categorized in two distinctive sections, where the first category titled as Market Overview provides a holistic view of the market, key trends, drivers, challenges/restraints or opportunities with their current and expected impact on the overall industry sales. 
Our analyst implement several qualitative tools such as Ansoff’s Matrix, PESTEL analysis, Porter’s five force analysis among other to interpret and represent key industry findings. 
The second section of the study provides market size, estimates and forecast for key market segments and regional market. The final part of the report highlights key manufacturers/vendors operating in the associated market. 


1. Introduction
1.1. Market Definition
1.2. Market Scope


2. Research Methodology
2.1. Primary Research
2.2. Secondary Sources
2.3. Assumptions & Exclusions


3. Market Overview
3.1. Research Report Segmentation & Scope
3.2. Key Market Trend Analysis
3.2.1. Market Drivers
3.2.2. Market Restraint/Challenges
3.2.3. Market Opportunities
3.3. Porter’s Five Forces Analysis
3.4. Potential Venture Avenues
3.5. Market Share Analysis, 2016 
3.6. Market Overview


4. Type Overview
4.1. Introduction
4.2. Market Size & Forecast, 2015 to 2025
4.2.1. Drug discovery 
4.2.2. Pre-clinical 
4.2.3. Clinical based
 (Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


5. Services Overview
5.1. Introduction
5.2. Market Size & Forecast, 2015 to 2025
5.2.1. Clinical Supply Management 
5.2.2. Data Management 
5.2.3. Regulatory 
5.2.4. Medical Writing 
5.2.5. Clinical Monitoring 
5.2.6. Quality Management 
5.2.7. Bio-statistics 
5.2.8. Investigator Payments 
5.2.9. Laboratory Patient 
5.2.10. Site Recruitment Technology 
5.2.11. Others
 (Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


6. Regional Overview
6.1. Introduction
6.2. Market Size & Forecast, 2015 to 2025
6.2.1. North America
6.2.1.1. U.S.
6.2.1.2. Canada
6.2.1.3. Mexico 
6.2.2. Europe
6.2.2.1. UK
6.2.2.2. Germany
6.2.2.3. France
6.2.2.4. Italy 
6.2.2.5. Spain
6.2.2.6. Rest of Europe
6.2.3. Asia-Pacific
6.2.3.1. China
6.2.3.2. India
6.2.3.3. Japan
6.2.3.4. South Korea
6.2.3.5. Rest of Asia-Pacific
6.2.4. LAMEA
6.2.4.1. Brazil
6.2.4.2. UAE
6.2.4.3. South Africa
6.2.4.4. Rest of LAMEA
(Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


7. Manufacturer/ Vendor Profile
7.1. The following attributes will be considered while profiling key manufacturers in this industry: 
7.1.1. Company Overview
7.1.2. Financial Synopsis
7.1.3. Recent Developments
7.1.4. R&D Investments (if any)
7.1.5. Strategy Overview (Analyst Perspective)
7.1.6. Product Portfolio
7.2. Companies Profiled
7.2.1. PAREXEL International 
7.2.2. Charles River 
7.2.3. Medpace
7.2.4. Pharmaceutical Product Development, LLC. 
7.2.5. Syneos Health 
7.2.6. IQVIA 
7.2.7. PRA Health Sciences, Inc. 
7.2.8. ICON PLC 
7.2.9. Quintiles
7.2.10. Laboratory Corporation of America Holdings etc.  
 (Note: The companies mentioned above are tentative in nature, and profiles of other market players not listed here can be included on request.) 

Request Sample

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?

Request Discount

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?

Related Reports




Get 15 minutes of free Consultation When you request a Sample Report!

24/7 Research Report

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone:

+1 513 549 5911 (US)

+44 203 318 2846 (UK)

Email: [email protected]